1-Jahres-Chart (nicht börsennotiert)
- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 04.10. | LumiraDx Ltd - 6-K, Report of foreign issuer | 2 | SEC Filings | ||
| LUMIRADX Aktie jetzt für 0€ handeln | |||||
| 01.08. | BioPharma Credit PLC - STATEMENT RE LUMIRADX | 5 | RNS | ||
| 29.07. | Roche Closes Acquisition Of LumiraDx's Point Of Care Technology | 473 | AFX News | SOUTH SAN FRANCISCO (dpa-AFX) - Roche Holding AG (RHHBY), a Swiss healthcare major, on Monday said that it has concluded the previously announced acquisition of LumiraDx Limited's (LMDX) Point... ► Artikel lesen | |
| 29.07. | BioPharma Credit PLC - STATEMENT RE LUMIRADX | 5 | RNS | ||
| 29.07. | F. Hoffmann-La Roche Ltd: Roche closes acquisition of LumiraDx's Point of Care technology to expand access to diagnostic testing in primary care | 626 | GlobeNewswire (Europe) | The acquisition of LumiraDx's Point of Care technology received all required antitrust and regulatory clearances.LumiraDx's transformative Point of Care solution will complement Roche's diagnostics... ► Artikel lesen | |
| 24.05. | Competition Watchdog CMA Issues Prelim. Notice To Roche On Its Merger Plan With LumiraDx | 572 | AFX News | SOUTH SAN FRANCISCO (dpa-AFX) - The Competition and Markets Authority or CMA on Friday said that it has issued a notice regarding Roche's planned acquisition of certain assets of LumiraDx, under... ► Artikel lesen | |
| 24.05. | Britische Wettbewerbsaufsicht CMA prüft Roche-LumiraDx-Deal | 562 | Dow Jones News | DJ Britische Wettbewerbsaufsicht CMA prüft Roche-LumiraDx-Deal
Von Michael Susin
LONDON (Dow Jones)--Die britische Wettbewerbs- und Marktaufsichtsbehörde CMA hat eine Prüfung der Übernahme... ► Artikel lesen | |
| 20.05. | CMA Invites Views From Interested Parties On Roche, LumiraDx Deal | 573 | AFX News | SOUTH SAN FRANCISCO (dpa-AFX) - The UK's Competition and Markets Authority or CMA said on Monday that it decided to investigate the planned acquisition by Roche Diagnostics Limited ((RHHBY))... ► Artikel lesen | |
| 20.05. | CMA wägt mögliche Auswirkungen von Roche-LumiraDx-Deal ab | 602 | Dow Jones News | DJ CMA wägt mögliche Auswirkungen von Roche-LumiraDx-Deal ab
Von Mauro Orru
LONDON (Dow Jones)--Die britische Wettbewerbs- und Marktaufsichtsbehörde CMA prüft, ob die Übernahme sogenannter... ► Artikel lesen | |
| 20.03. | Delisting of Securities of Latch, Inc.; Eloxx Pharmaceuticals, Inc.; Collective Audience, Inc. (f.k.a., ABRIC SPAC I); SeqLL Inc.; Nemaura Medical Inc.; LumiraDx Limited; Cemtrex Inc.; COMSovereign Holding Corp.; Global System Dynamics; Arrival ... | 390 | GlobeNewswire (Europe) | NEW YORK" March 20, 2024 (GLOBE NEWSWIRE) -- The Nasdaq Stock Market announced today that it will delist the common stock and warrants of Latch, Inc. Latch, Inc.'s securities were suspended on August... ► Artikel lesen | |
| 05.01. | LumiraDx Limited: LumiraDx Announces its Securities will be Suspended from Trading on Nasdaq at the Open of Business on January 9th | 500 | GlobeNewswire (Europe) | LONDON, Jan. 05, 2024 (GLOBE NEWSWIRE) -- LumiraDx Limited (Nasdaq: LMDX)(the "Company") today announced that it has received notification from The Nasdaq Stock Market LLC ("Nasdaq") that its securities... ► Artikel lesen | |
| 29.12.23 | F. Hoffmann-La Roche Ltd: Roche enters into a definitive agreement to acquire LumiraDx's Point of Care technology combining multiple diagnostic modalities on a single platform | 1.062 | GlobeNewswire (Europe) | The transformative point of care solution will complement Roche's centralised diagnostics portfolio across Clinical Chemistry, Immunochemistry, Coagulation and Molecular, and across multiple disease... ► Artikel lesen | |
| 29.12.23 | LumiraDx Limited: LumiraDx Announces Agreement to Sell its Cutting Edge Point of Care Technology Platform to Roche | 905 | GlobeNewswire (Europe) | LONDON, Dec. 29, 2023 (GLOBE NEWSWIRE) -- LumiraDx Limited (Nasdaq: LMDX) (the "Company"), a next generation point of care diagnostics company, announced today the appointment of joint administrators... ► Artikel lesen |
13 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| EMEIS | 5,376 | +0,62 % | emeis announces €251m in disposals of real estate and operating assets since the beginning of October | Nearly €900 million in disposals completed since mid-2022 or secured to date Disposal of activities in Chile and the Czech Republic
Regulatory News:
emeis (Paris:EMEIS) today announced... ► Artikel lesen | |
| TEMPEST THERAPEUTICS | 0,815 | +0,25 % | Tempest Therapeutics: Tempest Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) | BRISBANE, Calif., Dec. 06, 2024 (GLOBE NEWSWIRE) -- Tempest Therapeutics, Inc. (Nasdaq: TPST), a clinical-stage biotechnology company developing first-in-class1 targeted and immune-mediated therapeutics... ► Artikel lesen | |
| NANO-X IMAGING | 7,015 | 0,00 % | Nano-X Imaging LTD.: Nanox.ARC Imaging System Receives FDA Clearance for General Use, Including Pulmonary Indication | Nanox.ARC receives additional FDA clearance to produce tomographic images for general use, including pulmonary, intra-abdominal and paranasal indications, in addition to its previously cleared indication... ► Artikel lesen | |
| BUTTERFLY NETWORK | 3,085 | 0,00 % | Butterfly Network Reports Third Quarter 2024 Financial Results | BURLINGTON, Mass. & NEW YORK--(BUSINESS WIRE)--Butterfly Network, Inc. (NYSE: BFLY) ("Butterfly" or the "Company"), a digital health company transforming care with portable, semiconductor-based... ► Artikel lesen | |
| CARMAT | 1,022 | -3,04 % | CARMAT optimizes its financial structure by buying-back, for a symbolic sum of one euro, 2 million shares from Matra-Défense (Airbus group) which will be allocated to the repayment of its financial debt | Buy-back by CARMAT of 2 million shares from Airbus for a symbolic sum of 1 euro. The shares so bought-back will be allocated to the repayment of the Company's financial debt, via their... ► Artikel lesen | |
| INTELLIGENT BIO SOLUTIONS | 1,475 | 0,00 % | Intelligent Bio Solutions, Inc.: Intelligent Bio Solutions Announces 510(k) Submission to US FDA for Fingerprint Sweat-Based Drug Screening Technology | NEW YORK, Dec. 18, 2024 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (Nasdaq: INBS) ("INBS" or the "Company"), a medical technology company delivering intelligent, rapid, non-invasive testing... ► Artikel lesen | |
| GOODRX | 4,445 | 0,00 % | GoodRx Reports Third Quarter 2024 Results | SANTA MONICA, Calif.--(BUSINESS WIRE)--GoodRx Holdings, Inc. (Nasdaq: GDRX) ("we," "us," "our," "GoodRx," or the "Company"), the leading prescription savings platform in the U.S., has released... ► Artikel lesen | |
| JOINT CORP | 10,100 | 0,00 % | JOINT Corp - 8-K, Current Report | ||
| TALKSPACE | 3,040 | 0,00 % | Espresa Partners with Talkspace to Boost Employee Well-Being with Accessible Mental Health Benefits | Espresa has partnered with Talkspace to expand mental health support for employees. Through Espresa's platform, clients now have access to Talkspace's 5,000+ licensed therapists, offering secure, on-demand... ► Artikel lesen | |
| MIMEDX | 9,140 | 0,00 % | MiMedx Group, Inc: MIMEDX Announces Third Quarter 2024 Operating and Financial Results | Net Sales of $84 million Grew 3% Year-Over-Year for the Third QuarterThird Quarter GAAP Net Income and Earnings Per Share were $8 Million and $0.05, RespectivelyThird Quarter Adjusted EBITDA was $18... ► Artikel lesen | |
| PROCEPT BIOROBOTICS | 83,46 | 0,00 % | PROCEPT BioRobotics Reports Third Quarter 2024 Financial Results and Increases 2024 Revenue and Adjusted EBITDA Guidance | SAN JOSE, Calif., Oct. 28, 2024 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics Corporation (Nasdaq: PRCT) (the "Company"), a surgical robotics company focused on advancing patient care by developing transformative... ► Artikel lesen | |
| HYPERFINE | 0,870 | 0,00 % | Hyperfine, Inc.: Hyperfine Expands Global Market Reach with New Distribution Partnerships in European and Middle Eastern Markets | Strategic agreements set the stage for further global adoption of portable MR brain imaging technology, fueling expansion plans for 2025.
Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking health... ► Artikel lesen | |
| ATRICURE | 30,420 | 0,00 % | Pre-market Movers: ASP Isotopes, NerdWallet, Reddit, AtriCure, Qorvo | OLATHE (dpa-AFX) - The following are some of the stocks making big moves in Wednesday's pre-market trading (as of 08.05 A.M. ET).In the Green ASP Isotopes Inc. (ASPI) is up over 44% at $8.33.
NerdWallet... ► Artikel lesen | |
| BIOMERICA | 0,275 | 0,00 % | BIOMERICA INC - S-8, Securities to be offered to employees in employee benefit plans | ||
| PROPHASE LABS | 0,650 | 0,00 % | ProPhase Labs stock hits 52-week low at $0.64 amid sharp decline |
Das Unternehmen LUMIRADX LIMITED kann der Branche Gesundheitswesen zugeordnet werden. Mit einer aktuellen Kursveränderung von 0,000 (-1,25 %) liegt der Kurs bei 0,016 Euro.
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu LUMIRADX LIMITED finden Sie auf Wallstreet Online.
